|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06078 HYGEIA HEALTH
Nominal 
16.400 -1.420 (-7.969%) Ranking Overview
Ranking based on 12 research report(s)
Average Ranking 2.00
|
Strong Buy (1)
0
|
Buy (2)
12
|
Hold (3)
0
|
Sell (4)
0
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2023 | EPS | 108.00 RMB (cts) | |
| Net Profit | 682.93 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2024 | 805.00 | 127.00 | 0 | -- | 1,056.00 | 753.00 |
| 2025 | 953.00 | 151.00 | 0 | -- | 1,298.00 | 866.00 |
| 2026 | 1,181.50 | 187.20 | 0 | -- | 1,527.00 | 1,025.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2024 | 1,056.00 | 167.00 | -- | UBS | Buy | 73.00 | 30/05/2024 | |
| 2024 | 817.00 | 129.00 | -- | NOMURA | Buy | 50.70 | 16/07/2024 | |
| 2024 | 868.98 | 138.00 | -- | MORGAN STANLEY | Overweight | 45.00 | 07/07/2024 | |
| 2024 | 823.20 | 130.00 | -- | GOLDMAN SACHS | Buy | 43.00 | 01/09/2024 | |
| 2024 | 783.00 | 124.00 | -- | CITIGROUP | Buy | 38.00 | 02/09/2024 | |
| 2024 | 779.00 | 123.00 | -- | HAITONG | OutPerform | 35.17 | 09/09/2024 | |
| 2024 | 753.00 | 119.00 | 35.80 | BANK OF AMERICA | Buy | 33.00 | 30/08/2024 | |
| 2024 | 845.00 | 128.00 | 12.80 | BOCI | Buy | 31.00 | 02/09/2024 | |
| 2024 | 782.00 | 124.00 | -- | CICC | OutPerform | 25.00 | 05/09/2024 | |
| 2024 | 788.00 | 125.00 | 37.00 | HSBC | Buy | 25.00 | 10/09/2024 | |
| 2024 | 793.00 | 126.00 | -- | BOCOM | Buy | 24.50 | 02/09/2024 | |
| 2024 | 824.00 | 130.00 | -- | ZHONGTAI INT'L SEC | Buy | 22.30 | 13/11/2024 | |
| 2025 | 1,298.00 | 206.00 | -- | UBS | -- | -- | 30/05/2024 | |
| 2025 | 1,020.00 | 161.00 | -- | NOMURA | -- | -- | 16/07/2024 | |
| 2025 | 1,111.79 | 176.00 | -- | MORGAN STANLEY | -- | -- | 07/07/2024 | |
| 2025 | 1,075.30 | 170.00 | -- | GOLDMAN SACHS | -- | -- | 01/09/2024 | |
| 2025 | 872.00 | 138.10 | -- | CITIGROUP | -- | -- | 02/09/2024 | |
| 2025 | 866.00 | 137.00 | -- | HAITONG | -- | -- | 09/09/2024 | |
| 2025 | 881.00 | 139.00 | 41.80 | BANK OF AMERICA | -- | -- | 30/08/2024 | |
| 2025 | 997.00 | 158.60 | 15.90 | BOCI | -- | -- | 02/09/2024 | |
| 2025 | 911.00 | 144.00 | -- | CICC | -- | -- | 05/09/2024 | |
| 2025 | 922.00 | 146.00 | 44.00 | HSBC | -- | -- | 10/09/2024 | |
| 2025 | 936.00 | 148.00 | -- | BOCOM | -- | -- | 02/09/2024 | |
| 2025 | 970.00 | 154.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 13/11/2024 | |
| 2026 | 1,527.00 | 242.00 | -- | UBS | -- | -- | 30/05/2024 | |
| 2026 | 1,255.00 | 199.00 | -- | NOMURA | -- | -- | 16/07/2024 | |
| 2026 | 1,382.76 | 219.00 | -- | MORGAN STANLEY | -- | -- | 07/07/2024 | |
| 2026 | 1,361.30 | 216.00 | -- | GOLDMAN SACHS | -- | -- | 01/09/2024 | |
| 2026 | 1,025.00 | 162.50 | -- | CITIGROUP | -- | -- | 02/09/2024 | |
| 2026 | 1,027.00 | 163.00 | 48.80 | BANK OF AMERICA | -- | -- | 30/08/2024 | |
| 2026 | 1,188.00 | 188.40 | 18.80 | BOCI | -- | -- | 02/09/2024 | |
| 2026 | 1,089.00 | 172.00 | 52.00 | HSBC | -- | -- | 10/09/2024 | |
| 2026 | 1,175.00 | 186.00 | -- | BOCOM | -- | -- | 02/09/2024 | |
| 2026 | 1,084.00 | 172.00 | -- | ZHONGTAI INT'L SEC | -- | -- | 13/11/2024 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 22/11/2024 17:59 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 384,571 |
| %Change | 15.094% |
| EPS / (LPS) | RMB 0.610 |
| NBV Per Share (¥) | RMB 10.493 |